Why the study?
The true risk of sudden cardiac death in asymptomatic Wolff-Parkinson-White syndrome remains unclear, literature on optimal management is controversial, and existing risk stratification tests are inadequate in infants.
Sudden cardiac death can be the first clinical manifestation in infants with asymptomatic Wolff-Parkinson-White syndrome, highlighting a critical gap in current risk stratification methods.
Answers are grounded in this paper and cite their sources.
Warrants vigilance for SCD in asymptomatic infant WPW; leaves open improved risk stratification.
The real risk of sudden cardiac death (SCD) in asymptomatic Wolff-Parkinson-White syndrome (AWPWS) is still not well known, and controversial literature is found about the best management strategy. Most worrisome is that SCD has been reported as the first event in asymptomatic or undiagnosed AWPWS infants. So adequate risk stratification to prevent the occurrence of life-threatening arrhythmias is warranted in these patients, but none of the available tests for this is a good option.
No takes yet. Share an insight, caveat, or question.
Rodríguez‐González et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: